Integrated Lifecycle Solutions and Stronger Customer Relationships
First written in FY2016. 22 of 26 entries say "Restated". Latest entry: 2026-05-14.
The whole theme swung hardest in 2017: 2 of 11 companies on the "Worse" side.
10 other companies' latest entry also says "Advanced".
- 2026-05-14AdvancedEarnings
「具体的には、これまで同様特定の分野に偏ることなくバランスの取れた受注を推進するとともに、」
産業設備工事の受注高が前期比11.6％増加し、特定分野に偏らないバランスの取れた受注方針を継続している。 - FY2026-H1RestatedAnnual report
「Against this backdrop, the Group is implementing measures to achieve the growth strategies set out in its long-term management vision “TECHNO RYOWA 2032” and its “three-year medium-term business plan,” including promoting balanced order-taking activities centered on industrial facilities, enhancing corporate value through CSR activities and improving productivity through DX.」
Continues to pursue balanced order-taking activities centered on industrial facilities based on the long-term management vision and medium-term plan. - FY2025-H1AdvancedAnnual report
「Revenue increased 10.6% year on year to ¥35,023 million, compared with ¥31,671 million in the same period of the previous year. This was due to steady progress on projects on hand and higher revenue from the maintenance division.」
For the existing themes of end-to-end lifecycle solutions and capturing maintenance demand, the increase in maintenance-division revenue is cited as a realized result. - FY2024RestatedAnnual report
「While continuing to promote balanced order-taking activities centered on industrial facilities, including pharmaceutical, food and electronic-device-related facilities, we have worked to improve operational efficiency in response to chronic staff shortages and amendments to the Labor Standards Act applicable from fiscal 2024. We have also strengthened our construction capabilities through information sharing among offices and efficient personnel allocation.」
Continues balanced order-taking centered on industrial facilities, operational efficiency improvements, information sharing among offices and stronger construction capabilities through personnel allocation. - FY2024-Q1RestatedAnnual report
「Against this backdrop, to respond to intensifying competition, the Group continues to promote balanced order-taking activities centered on industrial facilities, including pharmaceutical, food and electronic-device-related facilities, while implementing measures such as further promoting work-style reform and undertaking ESG initiatives.」
Continues to pursue balanced order-taking activities centered on industrial facilities, including pharmaceutical, food and electronic-device-related facilities. - FY2023RestatedAnnual report
「The Group is actively capturing demand for maintenance and servicing at operating factories and other facilities, while pursuing the construction of a business structure less affected by economic trends under its basic management strategy of promoting a balanced order portfolio.」
Continues to capture maintenance and servicing demand and build a stable business foundation through a balanced order portfolio. - FY2023-Q3RestatedAnnual report
「Against this backdrop, to respond to intensifying competition, the Group continues to promote balanced order-taking activities centered on industrial facilities, including pharmaceutical, food and electronic-device-related facilities, while implementing measures such as further promoting work-style reform and undertaking ESG initiatives.」
Continues to pursue balanced order-taking activities centered on industrial facilities and implements work-style reform and ESG initiatives as measures. - FY2023-Q2RestatedAnnual report
「Against this backdrop, to respond to intensifying competition, the Group continues to promote balanced order-taking activities centered on industrial facilities, including pharmaceutical, food and electronic-device-related facilities, while implementing measures such as further promoting work-style reform and undertaking ESG initiatives.」
Continues to pursue balanced order-taking activities centered on industrial facilities, including pharmaceutical, food and electronic-device-related facilities. - FY2023-Q1RestatedAnnual report
「Against this backdrop, to respond to intensifying competition, the Group continues to promote balanced order-taking activities centered on industrial facilities, including pharmaceutical, food and electronic-device-related facilities, while implementing measures such as further promoting work-style reform and undertaking ESG initiatives.」
Although the phrase “end-to-end lifecycle solutions” is not used, the Group continues to pursue balanced order-taking activities centered on industrial facilities. - FY2022-Q3RestatedAnnual report
「Against this backdrop, the Group has implemented measures in line with the basic policies of the three-year medium-term business plan, for which the current consolidated fiscal year is the first year, including continuing to pursue balanced order-taking activities in response to intensifying competition, promoting work-style reform and undertaking ESG initiatives.」
In the first year of the new three-year medium-term business plan, the Group continues to pursue balanced order-taking activities. No new progress concerning end-to-end lifecycle solutions is described. - FY2022-Q2RestatedAnnual report
「Against this backdrop, the Group has implemented measures in line with the basic policies of the three-year medium-term business plan, for which the current consolidated fiscal year is the first year, including continuing to pursue balanced order-taking activities in response to intensifying competition, promoting work-style reform and undertaking ESG initiatives.」
In the first year of the new three-year medium-term business plan, the Group continues to pursue balanced order-taking activities. - FY2022-Q1RestatedAnnual report
「Against this backdrop, the Group has implemented measures in line with the basic policies of the three-year medium-term business plan, for which the current consolidated fiscal year is the first year, including continuing to pursue balanced order-taking activities in response to intensifying competition, promoting work-style reform and undertaking ESG initiatives.」
In the first year of the new three-year medium-term business plan, the Group continues to pursue balanced order-taking activities in response to intensifying competition. - FY2021-Q3RestatedAnnual report
「Going forward, while continuing to monitor the situation surrounding COVID-19, we will pursue a balanced order portfolio centered on industrial facility projects, including food-related, pharmaceutical-related and electronic-device-related projects, based on the basic policies set out in our three-year medium-term business plan, with the aim of establishing a business foundation less susceptible to economic trends.」
Reaffirms the policy of pursuing a balanced order portfolio in industrial facility projects, including food-related, pharmaceutical-related and electronic-device-related projects, and building a business foundation less affected by economic conditions. - FY2021-Q2RestatedAnnual report
「Going forward, while continuing to monitor the situation surrounding COVID-19, we will pursue a balanced order portfolio centered on industrial facility projects, including food-related, pharmaceutical-related and electronic-device-related projects, based on the basic policies set out in our three-year medium-term business plan, with the aim of establishing a business foundation less susceptible to economic trends.」
Continues the policy of pursuing a balanced order portfolio in industrial facility projects, now explicitly including electronic-device-related projects in addition to food-related and pharmaceutical-related projects. - FY2021-Q1RestatedAnnual report
「Going forward, while continuing to monitor the situation surrounding COVID-19, we will pursue a balanced order portfolio centered on industrial facility projects, including pharmaceutical-related and food-related projects, based on the basic policies set out in our three-year medium-term business plan, with the aim of establishing a business foundation less susceptible to economic trends.」
Reaffirms the policy of pursuing a balanced order portfolio in industrial facility projects, including pharmaceutical-related and food-related projects, and building a business foundation less affected by economic conditions despite the impact of COVID-19. - FY2020-Q3RestatedAnnual report
「Against this backdrop, the Group has reaffirmed its policy of pursuing a balanced order portfolio centered on industrial facility projects, including pharmaceutical-related and food-related projects, without being focused solely on expanding scale, based on the basic policies set out in its three-year medium-term business plan.」
Reaffirms the policy of pursuing a balanced order portfolio in industrial facility projects, including pharmaceutical-related and food-related projects, without prioritizing scale expansion. - FY2020-Q2RestatedAnnual report
「Against this backdrop, the Group has reaffirmed its policy of pursuing a balanced order portfolio centered on industrial facility projects, including pharmaceutical-related and food-related projects, without being focused solely on expanding scale, based on the basic policies set out in its three-year medium-term business plan.」
Continues to pursue a balanced order portfolio in industrial facility projects, including pharmaceutical-related and food-related projects, under the three-year medium-term business plan, with the aim of building a business foundation less affected by economic conditions. - FY2020-Q1RestatedAnnual report
「Against this backdrop, the Group has reaffirmed its policy of pursuing a balanced order portfolio centered on industrial facility projects, including pharmaceutical-related and food-related projects, without being focused solely on expanding scale, based on the basic policies set out in its three-year medium-term business plan.」
Continues to pursue a balanced order portfolio in industrial facility projects, including pharmaceutical-related and food-related projects, under the three-year medium-term business plan, with the aim of building a business foundation less affected by economic conditions. - FY2018-Q3RestatedAnnual report
「Against this backdrop, the Group focused on securing orders for industrial facility-related projects, particularly in pharmaceutical-related fields, while promoting its end-to-end lifecycle solutions business to reliably capture demand for facility improvement projects.」
Continues to secure orders, particularly in pharmaceutical-related fields, and promote end-to-end lifecycle solutions to capture demand for facility improvement projects. - FY2018-Q2RestatedAnnual report
「Against this backdrop, the Group focused on securing orders for industrial facility-related projects, particularly in pharmaceutical-related fields, while promoting its end-to-end lifecycle solutions business to reliably capture demand for facility improvement projects.」
Continues the integrated life-cycle solutions business to capture demand for equipment improvement work. - FY2018-Q1RestatedAnnual report
「Against this backdrop, the Group focused on securing orders for industrial facility-related projects, particularly in pharmaceutical-related fields, while promoting its end-to-end lifecycle solutions business to reliably capture demand for facility improvement projects.」
Continues the integrated life-cycle solutions business to capture demand for equipment improvement work. - FY2017RaisedAnnual report
「To strengthen relationships with customers, we will advance our integrated life-cycle solutions business and expand the number of customers covered.」
In addition to continuing integrated life-cycle solutions and strengthening customer relationships, explicitly identifies expanding the customer base as a policy under the medium-term plan. - FY2017-Q3RestatedAnnual report
「Against this backdrop, our group has continued to promote its integrated life-cycle solutions business to capture steady demand for equipment improvement work, while strengthening consultative sales for industrial facilities, particularly in pharmaceutical-related fields, and expanding operations in Southeast Asia.」
Continues the integrated life-cycle solutions business to capture demand for equipment improvement work. - FY2017-Q2RestatedAnnual report
「Against this backdrop, our group has continued to promote its integrated life-cycle solutions business to capture steady demand for the equipment improvement work in which we have traditionally specialized, while strengthening consultative sales for industrial facilities, particularly in pharmaceutical-related fields, and expanding operations in Southeast Asia.」
Continues the integrated life-cycle solutions business to capture demand for equipment improvement work. - FY2017-Q1RestatedAnnual report
「We continued initiatives including expanding solution-based sales for industrial facilities, particularly in the pharmaceutical-related field, promoting our integrated lifecycle solutions business to strengthen customer relationships, and expanding the scale of our overseas business over the longer term, thereby working to strengthen our management foundation.」
Continues to promote integrated lifecycle solutions and strengthen customer relationships. - FY2016First statedAnnual report
「To capture steady demand for the equipment improvement work in which we have traditionally specialized, we continued to promote our integrated lifecycle solutions business and worked to build trust-based relationships with customers.」
Combines solutions covering the entire lifecycle with trust-based customer relationships, starting with equipment improvement work.